Jazz Pharmaceuticals PLC (JAZZ) is lower by -4.82% in a Week, Should You Accumulate?

A rating of 76 puts Jazz Pharmaceuticals PLC (JAZZ) near the top of the Biotechnology industry according to InvestorsObserver. Jazz Pharmaceuticals PLC's score of 76 means it scores higher than 76% of stocks in the industry. Jazz Pharmaceuticals PLC also received an overall rating of 50, putting it above 50% of all stocks. Biotechnology is ranked 87 out of the 148 industries.

JAZZ has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on JAZZ!

See Full JAZZ Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 50 would rank higher than 50 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Jazz Pharmaceuticals PLC Stock Today?

Jazz Pharmaceuticals PLC (JAZZ) stock is down -1.54% while the S&P 500 is up 1.59% as of 2:38 PM on Monday, Nov 29. JAZZ is lower by -$1.91 from the previous closing price of $124.09 on volume of 321,675 shares. Over the past year the S&P 500 is up 28.88% while JAZZ is lower by -13.17%. JAZZ lost -$2.55 per share the over the last 12 months. Click Here to get the full Stock Report for Jazz Pharmaceuticals PLC stock.